|
A.A. Grigorieva (1), L.V. Berzegova (1), K.V. Kozhina (1), E.V. Svechnikova (2)
Epi-Oral F199 – systemic anti-age therapy and antioxidant protection: ingredients
|
№8 / 2021
|
|
V.Ya. Dzerve
ENERGY METABOLISM CORRECTOR MILDRONATE®: INTERRELATION OF MECHANISMS OF ACTION AND THERAPEUTIC EFFECTS
|
№15 / 2017
|
|
A.I. Fedin, E.A. Tyutyumova, K.R. Badalyan
ISCHEMIC CASCADE IN THE ACUTE PERIOD OF THE STROKE AND METHODS OF ITS CORRECTION
|
№9 / 2017
|
|
M.V. Putilina
OPTIMIZATION OF THE CHOICE OF NEUROPROTECTIVE THERAPY IN ELDERLY PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA
|
№19 / 2016
|
|
V.N. Shishkova
KEY PATHOGENETIC MECHANISMS OF DEVELOPMENT OF ISCHEMIC INJURY AND POTENTIALS FOR THEIR CORRECTION IN PATIENTS WITH COMBINED CARDIOVASCULAR DISEASES
|
№13 / 2015
|
|
Yu.A. Kucheryavy
FEATURES OF MICRONUTRIENT STATUS IN PATIENTS WITH CHRONIC PANCREATITIS
|
№2 / 2015
|
|
S.Yu. Kalinchenko (1), L.O. Vorslov (1), I.A. Tyuzikov (2), Yu.A. Tishova (1)
OXIDATIVE STRESS AS CAUSE OF SYSTEMIC AGING. ROLE OF A-LIPOIC ACID ( ESPA-LIPON ) IN THE TREATMENT AND PREVENTION OF AGE-ASSOCIATED DISEASES
|
№6 / 2014
|
|
I.G. Semenova, M.F. Ballyuzek, F.A. Tugusheva
EFFICACY OF THERAPY OF PATIENTS WITH CHRONIC HEART FAILURE AND CARDIAC ARRHYTHMIAS USING DRUG CYTOCHROME C
|
№10 / 2013
|
|
I.V Ryabokon
Background For The Use Of Thiogamma In Stroke
|
№19 / 2012
|
|
A.V. Kalinin
Alcohol Abuse And Alcoholic Liver Disease
|
№13 / 2012
|
|
L.P. Sokolova, VI Shmyrev
Algorithm Of Therapeutic Action Of General Practitioner In Mild To Moderate (predemented) Cognitive Impairment
|
№11 / 2011
|
|
M.V Putilina, CH.K. Dongak
Role Of Endothelium Dysfunction In Formation Of Vascular Cognitive Disturbances: Possible Therapeutic Strategies
|
№12 / 2010
|
Русский
